chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pain in left arm; This is a spontaneous report from a non-contactable consumer, the patient. A 50-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies. The patient did not receive any medication within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 13:00, the patient experienced pain in left arm. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event pain in left arm was resolved on an unknown date in 2021.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Nausea, Diarrhea, Sore throat, headache and congestion. Started an hour after receiving the vaccination. Symptoms increased the following day.
nose bleeds for the last 2 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (nose bleeds for the last 2 days) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EPISTAXIS (nose bleeds for the last 2 days). At the time of the report, EPISTAXIS (nose bleeds for the last 2 days) outcome was unknown.            No treatment information was provided.  No concomitant medication was provided.
I received my first Moderna vaccine in March 2021.  I was unable to return for the second dose.  What can I do?; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I received my first Moderna vaccine in March 2021.  I was unable to return for the second dose.  What can I do?) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I received my first Moderna vaccine in March 2021.  I was unable to return for the second dose.  What can I do?). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I received my first Moderna vaccine in March 2021.  I was unable to return for the second dose.  What can I do?) had resolved.            No concomitant medication were provided by the reporter. No treatment medication were provided by the reporter.   Reporter did not allow further contact
Onset of itching at the sig right after getting the injection, then swelled and is itching and burning. No SOB or throat swelling. Hx flu shots with ever a reaction. No hx other allergic reaction, no egg allergies.
Hot at injection site; Redness at injection site; swollen at injection site; feverish (at injection site); This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)). At the time of the report, VACCINATION SITE WARMTH (Hot at injection site), VACCINATION SITE ERYTHEMA (Redness at injection site), VACCINATION SITE SWELLING (swollen at injection site) and PYREXIA (feverish (at injection site)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not reported. Treatment medication was not reported.
Cellulitis measuring 6x8cm. Warm and tender on exam. Treated with KEFLEX 250mg TID.
Information has been received from a 26 year old female for GARDASIL, a pregnancy registry product, concerning herself with no pertinent medical history or no allergies who in December 2007, was vaccinated with the first dose of GARDASIL. In February 2008 the patient was vaccinated with the second dose of GARDASIL. There was no concomitant medication. In March 2008 she found out she was one month pregnant by doing many pregnancy test which all came out positive. The patient reported that all the sonograms that she had during the pregnancy were normal, and at the time of delivery the babies head was turned in the cervix and the umbilical cord was caught so the patient had a c-section. The patient was at hospital for three days. The patient reported that the baby was delivered on 26-DEC-2008 and the baby was healthy. On 10-APR-2009 the patient was vaccinated with the third dose of GARDASIL. Additional information has been requested.
On April 24th, 5 days after the vaccine, "I" started "my" period. "I" am on BC that makes "me" not have "my" period. "I" am still taking "my" pill as normal, but "I" am experiencing a heavy flow and painful cramps.; On April 24th, 5 days after the vaccine, "I" started "my" period. "I" am on BC that makes "me" not have "my" period. "I" am still taking "my" pill as normal, but "I" am experiencing a heavy flow and painful cramps.; "I" was drinking so much and hardly peeing at all.; "I" was drinking so much and hardly peeing at all.; The night after getting the vaccine and carrying over through the next day, was excessively thirsty.  "I" was drinking so much and hardly peeing at all.; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the arm right on 19Apr2021 at 13:30(at the age of 34-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included birth control. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the vaccination. The concomitant medications included bupropion hydrochloride (WELLBUTRIN XL) for unspecified indication and norethisterone (NORETHINDRONE) for birth control, all from unknown dates and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0169) via an unspecified route of administration in the right arm on 26Mar2021 at 14:00(at the age of 33-years-old) as a single dose for COVID-19 immunisation. On 20Apr2021, the night after getting the vaccine and carrying over through the next day, the patient was excessively thirsty and was drinking so much and hardly peed at all. On 24Apr2021 at 07:00, 5 days after the vaccine the patient's period started. She was on her birth control (BC) that made her not had her period. She was taking her pill as normal at the time of report, but experienced a heavy flow and painful cramps. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events excessively thirsty, drinking so much, hardly peed, a heavy flow and painful cramps were not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
A serious spontaneous report of hives was received from a registered nurse/health professional concerning a four-year-old male, subsequent to H1N1, Intranasal. Patient was reported to be allergic to nuts. The patient had not received concomitant medication. On 24-Nov-2009, the patient received H1N1, Intranasal for an unknown indication. On the same day of vaccination, the patient experienced hives. The patient was administered diphenhydramine HCl. It is speculated that patient might have eaten gold fish that could have previously contained nuts. The patient remains well, and developed no other events from the vaccine. The outcome of the reported event was resolved. Additional information was received on 08-Dec-2009 and incorporated into the narrative: Concomitant medication, DOB, outcome of the event.
Shortly after receiving the Pfizer vaccination, I began to feel very dizzy and hot. I started sweating. I went to get up to tell one of the pharmacists and passed out while walking over to the desk. When I had passed out they were unsure if I was having an allergic reaction and so they used an epi pen. I started to come to and when I slowly made my way up and sat down I threw up.   I spoke with a doctor on 12/17/21 who had advised me to report the adverse event and speak with a professional to see if I am safe to get a different vaccine like the Moderna.
Patient was getting 2nd dose of Moderna vaccine. Approximately 5-10 minutes after, patient lost conscious in the waiting chair. Blood pressure was checked (88/51). 911 was called and patient was taken by EMT to be evaluated further.
Heather reports:  "redness and bumps to my face, down my neck, and down my left arm (that is the arm that I got the vaccine).  I took Claritan at facility and Benadryl at home.  The rash burned badly and was extremely itchy."  Heather stated that the symptoms resolved after taking the Benadryl.
This spontaneous report was received from an administrator, who was also a medical assistant and refers to a male patient of unknown age, starting medical school. No information about the patient's pertinent medical history, concomitant medications, drug reactions and allergies was provided. On an unknown date, when the patient was a child, he was vaccinated with 2 doses of M-M-R II (exact dose, route of administration, lot# and expiration date were not reported). On an unknown date, the patient had an unspecified test and the results showed low titre levels. The patient sought medical attention. The outcome of the event was reported as not recovered/not resolved. The causality assessment was not provided.
Several minutes (3-5) after receiving vaccine patient passed out. Patient did state that he was afraid of needles before receiving the vaccine although patient's wife said he has never passed out from one before. After paramedics arrived they checked his blood pressure and it was very low and they elected to take him to the hospital to be checked out. We have not heard back from the patient at this time.
This case was reported by a healthcare professional (medical assistant) via a sales representative and described the occurrence of injection site induration in a 15-month-old subject of unspecified gender who was vaccinated with INFANRIX (GlaxoSmithKline). In 2014 the subject received a dose of INFANRIX (unknown details). In 2014, within weeks of vaccination with INFANRIX, the subject experienced injection site induration (described as "knots at injection site") and injection site redness. The reporter noted that "the timeframe was is the past 2 weeks." The reporter stated that after the subject received INFANRIX, the subject "developed huge red knots at the injection site." No other events were reported. It was unknown if the immunization series was discontinued. At the time of reporting the outcome of the events were unknown. The healthcare professional considered the events were probably related to vaccination with INFANRIX. The medical assistant reported 4 other cases with INFANRIX. See A1060686A, A1060689A, A1060690A and A1060691A for details on the other cases.
Pt vax /w Hept-B experienced warm, flushing sensation, numbness, & tingling in the lt arm. Was hospitalized for dysequilibrium & paresthesias & dx with Multiple sclerosis.
Left arm began to ache, swell, was warm to the touch and red. Patient could hardly raise his arm.
1.Heart palpitation/left sitechest, squeezing 2. Chest muscle twitching 3. Left side chest pain-pressure 4. Hand/fingers and legs/toe tingling and numbness 5. Dizziness 6. Nausea 7. Headaches that moves into a different location 8. Terrible neck pain and throbbing 9. Weakness 10.  Ankle swollen  11. Breaking skin in my mouth and a pain in mouth and troat  12. Morning  coughing and swallowing (something) that extend to other hours a day 13. Dryness of the troat  14. Terrible weakness and unable to focus's to work without taking breaks every hour  15. Lost of the appetite  16. Bowel movement (concipation)  17. Less feeling of bladder emptiness
ITCHY EYES; BREATHING ISSUE; RED SPOTS; SORE ARM; BUMP BELOW INJECTION SITE; NOT ENERGETIC; SLIGHT HEADACHE ON AND OFF; This spontaneous report received from a patient concerned an 83-year-old female.  The patient's height, and weight were not reported. The patient's past medical history included: spinal surgery in 2013, and carotid artery surgery in 2010, and concurrent conditions included: asthma, chronic obstructive pulmonary disease (COPD), heart condition, pacemaker, and penicillin allergy, and other pre-existing medical conditions included the patient had allergy with unspecified pain medications and multiple other medications. The patient previously received covid-19 vaccine ad26. cov2. s (suspension for injection, route of admin not reported, batch number: unknown and expiry: unknown) 1 total, dose was not reported, administered on unspecified date for prophylactic vaccination (Dose number in series 1). The patient experienced no adverse events following vaccination with covid-19 vaccine ad26. cov2. s (Dose number in series 1).  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 211D21A and expiry: unknown) 1 total, dose was not reported, administered at left arm on 13-JAN-2022 for prophylactic vaccination (Dose number in series 2). The patient' s concomitant medications included blood thinners, the patient stated she bruises easily with blood thinners. On 13-JAN-2022, the patient stated after receiving booster shot she had reaction, sore arm (like if someone punched in the arm), bump below the injection site, red spots, feel not energetic, slight headache on and off, itchy eyes, breathing issue (the patient stated that it might be due to her asthma) (Dose number in series 2). She took 2 Tylenol and then the headache felt better. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from slight headache on and off, had not recovered from bump below injection site, sore arm, not energetic, itchy eyes, and red spots, and the outcome of breathing issue was not reported. This report was non-serious.
I had a sore throat, rash on upper chest and back and also a cough for about a week. I went to the doctor and drew my blood and found an issue with my CK-Protein total. I was given an IV to help with this protein level did not cause a blockage in my kidney. I spent 3 days in the emergency department. They told me stop taking statins. I was given ointment for my rash. After I went home, I began to have weakness, joint pain, shortness of breath and I was unable to open my mouth. I was then referred to rheumatologist and was diagnosed with Necrotizing Autoimmune Myopathy.
This case was reported by a consumer via call center representative and described the occurrence of fever in a adult female patient who received SHINGRIX for prophylaxis. In July 2018, the patient received SHINGRIX 1 ml. In July 2018, unknown after receiving SHINGRIX, the patient experienced overdose. On an unknown date, the patient experienced fever and injection site erythema. On an unknown date, the outcome of the fever, injection site erythema and overdose were unknown. It was unknown if the reporter considered the fever and injection site erythema to be related to SHINGRIX. Additional details were reported as follows: The age at vaccination was not reported. The age group was not provided, but was selected adult as per the vaccine indication. The physician's office reported that the patient received a 1.0 ml dose of SHINGRIX vaccine in left deltoid, which led to overdose. The patient experienced redness at the injection site. This case was linked with case US2018192689, reported by the same reporter.
completed Pfizer COVID vaccine 4/09/21, developed arm soreness 4/23/21 which resolved with Motrin, developed fatigue, ?fever and migraine headache on 4/24/21; temp 100.4 on 4-25-21; on 4/27/21 feels ok, little tired; no uri sx's, no known contacts w/COVID, No rashes, vomiting, diarrhea, loss of taste, travel
Severe pain at site, down arm and in shoulder. Finger also have pain. Pain at night cramping in arm - lost range of motion in arm. 2-visits to family Dr. X-Rays. Physical therapy. MRI. Visit to orthopaedic Dr two visits.
Confusion, Myalgia, Fever, Diarrhea & Tachycardia Narrative:
20 min after injection developed hives and itching all over. Gave her Allegra 150mg times 1, Albuterol MDI 2 puffs and Singular 10mg times 1
she has the pain, the swelling; she has the pain, the swelling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team, Program ID.  A female patient received rsv vaccine prot.subunit pref 2v (ABRYSVO), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN (non-serious), SWELLING (non-serious), outcome "unknown" and all described as "she has the pain, the swelling".  The information on the batch/lot number for rsv vaccine prot.subunit pref 2v, rsv vaccine prot.subunit pref 2v  has been requested and will be submitted if and when received.
sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in arm right, administration date 22Jan2021 15:00 (Lot number: EL9261) as dose 1, single and administered in arm right, administration date 13Feb2021 16:30 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "High cholesterol" (ongoing); "Allergies" (ongoing); "Calcium" (ongoing); "Vitamin" (ongoing). Concomitant medication(s) included: ZOCOR taken for blood cholesterol increased (ongoing); ZYRTEC [CETIRIZINE HYDROCHLORIDE] taken for hypersensitivity (ongoing); VITAMIN D [COLECALCIFEROL] taken for vitamin supplementation (ongoing); CALTRATE [CALCIUM CARBONATE] taken for mineral supplementation (ongoing); CENTRUM A TO ZINC taken for vitamin supplementation (ongoing). The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 23Jan2021 08:00, outcome "unknown", described as "sore arm".  Additional information: The patient had no prior vaccination. The patient's age at time of vaccination was reported as 65 or 66 years. The batch number for dose 2 was reported as GN620 (Could not read). The events were reported as non-serious. The patient did not undergo any relevant tests.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
5 minutes after administration of vaccine patient became very hot/body temp very high, sweating, felt like he was going to faint.  RPH gave him water, put an ice pack on the back of his neck and sat with him for 15 minutes. His body temp came back to normal after 15 minutes and he left.
UNSPECIFIED ADVERSE EVENTS; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: Unknown, and batch number: UNKNOWN expiry: UNKNOWN) .5 ml, administered on 04-MAR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021, the subject experienced unspecified adverse events. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of unspecified adverse events was not reported. This report was non-serious.
I had a sore arm and a slight headache the day after the Pfizer injection. I went out to the grocery and had a total panic attack.  I had to leave the store. It took amazing effort to do this. I then had to sit in my car for an hour and talk to a friend to de-escilate enough to drive home. I have spent the entire week very close to my bed. Even getting up and taking a shower causes me to panic- heart rate increase, shallow breathing, cold sweat, the feeling that I am coming out of my body or will pass out. All I have been doing is laying around for one week?s time. I have anxiety but nothing like this. I do not know if I should take the second injection. I am fearful that this will be so much worse after taking the second injection. I did call my PCP and the nurse did a phone review with me telling me that I should take the second injection and that anxiety / panic attacks are not a known side affect of this injection.
I saw patient on 4/5/2021 in a office setting. Patient received vaccine the evening of 3/27 (exact time unknown). He woke up the am of 3/28 with severe L hand swelling and itching. He then developed hives on trunk and neck. He reports 3-4 days after the vaccine he developed lip swelling. The swelling has gone down, but is still noticeably swollen on my exam on 4/5/2021. He still has wheels present on exam on trunk and neck.
I developed a rash around my neck, on my wrist, on my inner thighs, and under my arms. The rash could not be determined to be due to any known condition, and lasted for about 3 weeks. I went to Dr. , she ran full bloodwork. Rash did not go away after completion of antibiotics, or after taking Benadryl, Allegra and Xyzal for 14 days. Allergy medication was ceased after 2 weeks as it had no effect on the rash.
pt recvd MMR vax in AUG90 & NOV90; subsequently devel joint pain & muscle pain; 2 months later exp a burning sensation in the joints of knees & amrs; no further details were provided;
? Arm Pain     Got vaccines tetanus, Tdap , shingles, Hep a&B got two in each   Lower deltoid RT  Tdap & Shingles  LF Hep A&B  RT arm knot was there since she got the vaccines, the redness and warm to touch came yesterday,  had cold sweats x 2 days headache x 1 day    Pharmacy on 8/22
Significant uveitis in the right eye--redness of eye, vision loss, sensitivity to light, eye pain, headache.  Diagnosed on 1/24/22 after intense pain in right eye.  Treated with steroid eye drops.  I remain in treatment.